Nandrolone

A testosterone derivative sold as a decanoate ester ("Deca") or the shorter-acting phenylpropionate ("NPP"). One of the oldest injectable steroids, historically prescribed for anemia and wasting disease; non-medical use occurs in physique and performance settings.

Nandrolone is testosterone with one carbon removed (19-nortestosterone), and that single change rewrites its behaviour. It aromatises to estrogen far less than testosterone does, so it was historically sold as the "gentler" option — but it has meaningful progesterone-receptor activity instead, a pathway testosterone barely touches. The popular chain from that to its sexual and endocrine problems is NOT established — the historical label documents impotence, testicular suppression, low sperm counts, breast tissue changes and mood effects without establishing a cause, and those effects are multifactorial and incompletely characterised. The second quirk matters more: 5-alpha reductase converts nandrolone into DHN, a weaker androgen, the opposite of what happens to testosterone. That difference is why the scalp and prostate effects differ from testosterone's, though it does nothing to reduce how strongly it suppresses your own hormone production.

Real pharmaceutical history and real anabolic effect — nandrolone was a prescription drug for decades and trial data in wasting conditions shows lean-mass gain. For joints: subjective pain relief has LIMITED evidence — a small uncontrolled prospective pilot exists — while tendon or cartilage repair is NONE SHOWN. Nandrolone had FDA-approved use historically, but no currently marketed FDA-approved US product is listed; underground product is not equivalent to an approved one.

• Genuine prescription-era evidence exists for lean-mass gain and haemoglobin increase in wasting conditions, dialysis patients and certain anaemias — it was an approved drug for decades and the anabolic effect is not in question.
• HIV-wasting and dialysis studies through the 1990s remain the cleanest human data. Be precise about the dialysis one: 29 patients, lean mass improved (MODERATE), walking and stair-climbing reached only borderline significance and grip strength did not improve at all (functional benefit LIMITED). Extrapolating any of it to general wasting or to healthy performance: NONE SHOWN.
• The joint-comfort effect that drives most non-medical use has no controlled human trial. The proposed collagen-synthesis mechanism is plausible and preclinical; whether it heals anything or merely masks pain has never been tested in people.
• Sexual dysfunction on nandrolone is consistently reported and consistently under-explained — the mechanism is multifactorial (progestogenic activity, suppressed testosterone, altered estrogen ratio) and no single clean human study isolates it.

Formulations differ substantially in release and elimination, and the consequence people underestimate is on the exit rather than the entry: endocrine suppression can continue well past the point someone has stopped, outlasting measurable parent drug. Nandrolone is prohibited in tested sport. 19-norandrosterone is the marker used, and detectable long after any effect has gone.

Marked suppression of the hypothalamic-pituitary-gonadal axis that is widely reported as slow to recover, with libido and erectile dysfunction a common feature of that recovery window. Sexual and endocrine side effects are multifactorial and not fully explained by estrogen alone. Cardiovascular strain, lipid damage, and mood effects track other injectable AAS. It is prohibited in tested sport — ester- and assay-dependent.

• Class-level severe outcomes reported with anabolic steroids, which no compound here is exempt from: cardiac arrest, heart attack, thickened heart muscle, heart failure and stroke; serious liver injury; and mania, paranoia, psychosis, hostility, aggression, dependence and depression on withdrawal.
• Pregnancy and breastfeeding: androgens can cause fetal harm including virilisation of a female fetus. Avoid in both.
• Anyone who wants children in the foreseeable future — suppression can be marked and sperm recovery can persist well after exposure ends, though no reliable comparative ranking against other steroids exists.
• Anyone drug-tested in sport at any level — it is prohibited and produces violations.
• Anyone pregnant, or with prostate or male breast cancer, or female breast cancer with hypercalcaemia.
• Anyone with nephrosis or nephritic disease, or with heart, kidney or liver disease where fluid retention is a risk.
• Children, given the risk of premature growth-plate closure.
• Anyone with impaired glucose tolerance, and any woman for whom virilisation would be unacceptable — some of it does not reverse.
• Anyone with existing erythrocytosis, clotting history, or uncontrolled blood pressure.
• Anyone with a history of depression or significant mood instability — the mood and libido effects here are not rare.

• Anticoagulants — like other androgens, nandrolone can potentiate them.
• Aromatase inhibitors are frequently added on the assumption of estrogen control, but nandrolone aromatises poorly; over-suppressing estrogen on top of it is a documented route into crashed-estradiol symptoms.
• Finasteride does not protect the scalp here the way people assume — the 5-alpha pathway produces a weaker metabolite, so the drug is solving a problem this compound largely does not create.
• Any other suppressive androgen compounds the risk to the axis rather than adding to it.

• Total testosterone and LH/FSH — to see the depth of suppression, which tends to be more profound and slower to reverse than with testosterone alone.
• Prolactin — the progestogenic activity makes this the one hormone panel item people actually need here that they would not need on testosterone.
• Haematocrit and haemoglobin — the erythropoietic effect was a therapeutic indication, which is exactly why it overshoots outside a clinic.
• Lipids, especially HDL, and blood pressure.
• Semen analysis if fertility matters — recovery is slower here than with most compounds in this class.
• Mood and libido, tracked deliberately: these are the earliest and most reported signals that something has gone wrong.

The long ester means the compound is still working well after the last administration, so the recovery clock starts later than people expect. Beyond that, honesty requires dropping the forecast: endocrine and fertility recovery after anabolic-steroid use is variable, can take months, and can be incomplete — but there is no nandrolone-specific head-to-head timeline against testosterone, and no reliable way to predict an individual course. Anyone in a prolonged low-testosterone state after stopping needs medical assessment rather than a waiting period.

US: Schedule III anabolic steroid under the Controlled Substances Act — possession without a prescription is a federal offense. Products outside licensed dispensing are unapproved and quality-unverifiable.

Papers about this compound, not proof of the claims above. A title says what was studied, which is sometimes a negative result or a different question entirely.

• Effects of Nandrolone Decanoate on Muscle Strength, Body Composition and Bone Density: A Systematic Review and Meta-Analysis
  J Cachexia Sarcopenia Muscle, 2026
• Association between nandrolone and behavioral alterations: A systematic review of preclinical studies
  Steroids, 2021
• Nandrolone Decanoate: Use, Abuse and Side Effects
  Medicina (Kaunas), 2020

• Nandrolone: a multi-faceted doping agentHandb Exp Pharmacol · 2010
• Association between nandrolone and behavioral alterations: A systematic review of preclinical studiesSteroids · 2021
• Nandrolone decanoate: pharmacological properties and therapeutic use in osteoporosisClin Rheumatol · 1995
• Urine nandrolone metabolites: false positive doping test?Br J Sports Med · 2002
• The impact of nandrolone decanoate on the central nervous systemCurr Neuropharmacol · 2015
• Nandrolone combined with strenuous resistance training impairs myocardial proteome profile of ratsSteroids · 2021
• Nandrolone decanoate and testosterone undecanoate differently affect stress hormones, neurotransmitter systems, and general activity in the male ratBehav Brain Res · 2022
• Supraphysiological doses of nandrolone decanoate disrupts spermatogenesis but did not interfere on embryo rateNaunyn Schmiedebergs Arch Pharmacol · 2024
• Nandrolone decanoate safely combats catabolism in burned patients: A new potential indication after recallBurns · 2022
• Nandrolone decanoate induced kidney injury through miRNA-146a targeting IRAK1 and TRAF6 via activation of the NF-κB pathway: The effect of moderate exerciseSteroids · 2024
• Prevalence of nandrolone preparations with endogenous carbon isotope ratios in AustraliaDrug Test Anal · 2024
• Nandrolone improve synaptic plasticity at the hippocampus CA1 area and spatial localization in the Morris water maze of male adolescent ratsNeurosci Res · 2020